| Roche combo of breast cancer drugs shows modest benefit | | | CHICAGO (Reuters) - A clinical trial from Roche Holding AG combining the company's newer targeted drug for breast cancer with an older treatment resulted in a modest benefit for women with a specific type of disease, according to data presented on Monday. |
| |
| Seattle to become latest U.S. city to tax sugary drinks | | | SEATTLE (Reuters) - Seattle's City Council voted on Monday to levy a special tax on sodas and other sugary beverages sold to consumers, becoming the latest of several local government bodies across the country to take such action for the sake of public health. |
| |
| FDA approves new use for Edwards' Sapien 3 heart valve | | | (Reuters) - The U.S. Food and Drug Administration on Monday approved Edwards Lifesciences Corp's Sapien 3 artificial heart valve for high-risk patients whose previously implanted heart valves are failing, a procedure designed to avoid repeat open heart surgery. |
| |
| Big returns on small cancer research investment, study suggests | | | (Reuters Health) - A government-backed research collaboration program started in the 1950s has added about 3.34 million years of life for cancer patients in the U.S. at an estimated cost of just $125 for each year of life gained based on successful new treatment options developed through the program, a new study estimates. |
| |
| | |
